Press Releases

Against all SARS-CoV-2 Variants Development of a Potent, Broadly Protective Vaccine

In a recent study, researchers in China designed, produced, and evaluated the neutralization efficacy of...

Posted on November 18, 2022 by Admin

Neglected or Late TB Diagnoses Related to COVID-19 Reveals in Study

In a recent study published, researchers modeled changing patterns in sex- and age-stratified new and...

Posted on November 17, 2022 by Admin

Severity and Spread of COVID-19 can be Reduced by Vitamin D

In a recent study published, researchers in the United States assessed the relationship between supplementation...

Posted on November 16, 2022 by Admin

Against Latest Subvariants Modernas Bivalent Boosters Trigger Strong Antibody Response

Due to the continuous emergence of new immune evasive and more pathogenic variants of the...

Posted on November 15, 2022 by Admin

Against SARS-CoV-2 Main Protease Study Identifies Novel Inhibitors

In a recent study, researchers at the University of Arizona screened ~11 million severe acute...

Posted on November 14, 2022 by Admin

SARS-CoV-2 Omicron Variant BQ.1.1 shows Substantial Neutralization Escape

In a recent study posted, researchers at Beth Israel Deaconess Medical Center and Los Alamos...

Posted on November 11, 2022 by Admin

Does COVID-19 Severity Reduced with Vitamin D?

A recent review posted, examined published studies for a consistent association between vitamin D levels...

Posted on November 10, 2022 by Admin

Widespread SARS-CoV-2 Exposure in Wildlife Indicates Study

In a recent study posed, researchers at Virginia Tech University investigated wildlife exposure to SARS-CoV-2...

Posted on November 09, 2022 by Admin

During SARS-CoV-2 Beta, Delta and Omicron Variant Waves Persistent COVID-19 Symptoms among South Africans

In a recent study, researchers longitudinally followed up hospitalized (H) and non-hospitalized (NH) coronavirus disease...

Posted on November 08, 2022 by Admin

Extraordinary Immune Evasion Potential against Vaccine Sera was shown by SARS-CoV-2 Omicrons Newest Subvariant BQ.1.1

In a recent study, researchers pursued immunological evidence of why BQ.1.1 prevalence swiftly increased in...

Posted on November 07, 2022 by Admin